Weight-bearing of Surgically Treated Acetabular Fractures.

March 5, 2024 updated by: Kristian Seppänen, Hospital District of Helsinki and Uusimaa

Weight-bearing of Surgically Treated Acetabular Fractures. A Randomised Controlled Trial

The purpose of this study is to determine whether patients with operatively treated acetabular fractures benefit from early weight-bearing as tolerated. The study compares two groups ( n = 25 each), which are randomised into either weight-bearing as tolerated or touch-down weight-bearing for 6-8 weeks postoperatively.

Both study groups are stratified according to

  • Type of fracture (anterior approach vs anterior + additional posterior approach)
  • Dislocated dome vs non-dislocated/ non existing separate dome fragment

Patients, who are eligible to participate in the trial but choose not to participate in randomisation are asked to enrol in a prospective cohort follow-up cohort. This is to examine a potential participation bias in the RCT groups. These patients will not be counted into the target amount of 50 RCT patients.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

For the past 20 years, the established treatment of dislocated acetabular fractures has been surgical reduction and stable osteosynthesis. Good long-term results have been reported in these patients. At present, the mobilisation of these patients after surgery is generally restricted for several weeks ranging from 6-12 weeks touch-down- or non-weight-bearing with no uniform protocol. However there is no scientific evidence for limiting post operative weight-bearing. Accordingly the need of studies on weight-bearing surrounding periarticular fractures has been advocated.

Acetabular fractures in the elderly population are becoming more common and pose significant challenges for treatment including postoperative rehabilitation. Our aim is to investigate if patients benefit of a more liberal weight-bearing regime postoperatively. The primary outcome is measured at 1 year, secondary outcomes are followed up to 10 years postoperatively

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Uusimaa
      • Helsinki, Uusimaa, Finland, 00029 HUS
        • Helsinki University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Unilateral dislocated acetabulum fracture (displacement of over 2mm in preoperative CT scan)
  • The osteosynthesis is performed during 21 days after initial trauma
  • The patient is willing to participate in the follow-up

Exclusion Criteria:

  • Unwillingness to participate in randomisation
  • Bilateral fracture
  • Letournel & Judet type Both column or Posterior column and wall fractures
  • Any other injury that prevents the patient from partial weight bearing
  • Open fracture of the acetabulum
  • Pathologic fracture (fragility fractures are not an exclusion criteria)
  • Prior functional disability in the pelvis or lower extremity
  • Non-Compliance due to dementia or other mental disability
  • Prior daily pain medication due to hip-pain
  • Unwillingness to accept one of the two mobilisation protocols
  • Prior hip replacement on injured side
  • BMI > 40

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Weight-bearing as tolerated
Patients are instructed to mobilise the hip and weight-bear as tolerated

Approaches used:

  • Intrapelvic approach +/- iliac window
  • Kocher-Langenbeck approach
Active Comparator: Touch-down weight-bearing
Patients are instructed to mobilise the hip. Touch-down weight-bearing for 6-8 weeks

Approaches used:

  • Intrapelvic approach +/- iliac window
  • Kocher-Langenbeck approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mHHS
Time Frame: 1 year
Modified Harris Hip Score, Scale 0-100, higher scores mean better outcome
1 year
NRS
Time Frame: 1 year
Pain during gate, Numerical Rating Scale, Scale 0-10 0=no pain, 10=worst pain
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mHHS
Time Frame: 0 weeks, 6 weeks, 12 weeks, 6 months, 2 years, 5 years, 10 years
Modified Harris Hip Score, Scale 0-100, higher scores mean better outcome
0 weeks, 6 weeks, 12 weeks, 6 months, 2 years, 5 years, 10 years
NRS
Time Frame: 0 weeks, 6 weeks, 12 weeks, 6 months, 1 year, 2 years, 5 years, 10 years
Pain at rest and during gate (2 scores), Numerical Rating Scale, Scale 0-10 0=no pain, 10=worst pain
0 weeks, 6 weeks, 12 weeks, 6 months, 1 year, 2 years, 5 years, 10 years
WOMAC
Time Frame: 0 weeks, 1 year, 2 years, 5 years, 10 years
Western Ontario and McMaster Universities Osteoarthritis Index, Scale 0-96, higher scores mean better outcome
0 weeks, 1 year, 2 years, 5 years, 10 years
RAND36
Time Frame: 0 weeks, 1 Year, 2 years, 5 years, 10 years
Patient reported quality of life, Scale 0-100, higher scores mean better outcome
0 weeks, 1 Year, 2 years, 5 years, 10 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total hip replacement
Time Frame: During 10 years postoperatively
Conversion to total hip replacement
During 10 years postoperatively
Reduction of the articular surface after surgery
Time Frame: Postoperatively
The reduction is assessed with a postoperative CT scan
Postoperatively
Complications
Time Frame: At any point of time during treatment
Any complications during treatment are documented
At any point of time during treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jan Lindahl, MD, PhD, Helsinki University Central Hospital
  • Principal Investigator: Kristian Seppänen, MD, Helsinki University Central Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

January 22, 2021

First Submitted That Met QC Criteria

January 22, 2021

First Posted (Actual)

January 26, 2021

Study Record Updates

Last Update Posted (Actual)

March 6, 2024

Last Update Submitted That Met QC Criteria

March 5, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HUS/234/2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acetabular Fracture

Clinical Trials on Open reduction and internal fixation (ORIF)

3
Subscribe